The use of CT coronary calcium score in asymptomatic patients with familial hypercholesterolaemia
DOI:
https://doi.org/10.15277/bjdvd.2015.039Abstract
Background: Familial hypercholesterolaemia (FH) is associated with accelerated atherosclerosis. Diagnosis is based on clinical scores and only 45% of those with a clinical diagnosis have a genetic mutation known to be associated with FH. Coronary artery calcium (CAC) scoring can be used as a surrogate marker for coronary artery disease, but data on its use in FH are scarce.Methods: CAC was performed in 52 asymptomatic patients (16 ‘probable FH’ and 36 ‘possible FH’) classified according to modified Simon Broome criteria, who were attending a secondary care lipid clinic. Demographic and disease characteristics, CAC (Agatston) scores and arterial age were audited.
Results: Half the patients had an Agatston score of zero. In those with Agatston scores >0 and age >45 years, the mean arterial age was significantly higher than the chronological age (72 versus 59 years; p=0.0001). Only diabetes and hypertension status were significantly different between those with Agatston scores of 0 and >0 (p=0.045 and p=0.0175 respectively). Arterial age provided information useful for individualised clinical management.
Conclusions: Atherosclerosis burden varies widely in FH with diabetes mellitus and hypertension appearing to contribute. We have found the information from CT calcium scoring very useful in identifying those patients with significant atherosclerosis who would need more intensive treatment.
References
Austin M, Hutter CM, Zimmern RL, et al. Familial hypercholesterolaemia and CHD: a HuGE association review. Am J Epidemiol 2004;160:421-429.
Neefjes L, Ten Kate GJ, Rossi A, et al. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia. Heart 2011;97(14):1151-7. http://dx.doi.org/10.1136/hrt.2010.220699
Neefjes L, Ten Kate GJ, Alexia R, et al. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolaemia. Atherosclerosis 2011;219(2):721-7. http://dx.doi.org/10.1016/j.atherosclerosis.2011.09.052
Ho CK, Stirling D, Hannant W, et al. Genetic mutations in SE Scotland. Scott Med J 2012;57(3)148-151. http://dx.doi.org/10.1258/smj.2012.012020
The Cardiac Society of Australia and New Zealand. CSANZ guidelines for the diagnosis and management of familial hypercholesterolaemia. http://www.csanz.edu.au/wp-content/uploads/2013/12/Familial_Hypercholesterolemia_2013.pdf. 2010 (accessed 8 August 2014).
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/. 2014 (accessed 1 May 2015).
McClelland RL, Nasir K, Budoff M, et al. Arterial age as a function of coronary artery calcium (from the Multi-Ethnic study of Atherosclerosis [MESA]). Am J Cardiol 2009;103(1):59-63. http://dx.doi.org/10.1016/j.amjcard.2008.08.031
The Multi-Ethnic Study of Atherosclerosis. http://www.mesa-nhlbi.org/Calcium/ArterialAge.aspx. (accessed 10 January 2015)
Viladés Medel D, Leta Petracca R, Carreras Costa F, et al. Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.99992013;111(7):955-61. http://dx.doi.org/10.1016/j.amjcard.2012.12.012
National Institute for Health and Care Excellence (NICE) guidelines [CG71]. Identification and management of familial hypercholesterolaemia. http://www.nice.org.uk/Guidance/CG71. August 2008 (accessed 9 November 2014).
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
